The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a exciting advance. Unlike shots, this method offers a less invasive way to deliver GLP-1 therapies. These https://heathfeho014721.newbigblog.com/47857928/glp-1-patches-a-novel-approach-to-diabetes-management